Evidence map›Paper›PMID 40005967›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-

Balakumar Chandrasekaran, Mohammad F Bayan, Ali Hmedat, Bilal A Al-Jaidi, Deniz M Al-Tawalbeh, Duaa Abuarqoub, Anas J Rasras, Da'san M M Jaradat, Abdel Naser Dakkah, Wafa Hourani and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Balakumar ChandrasekaranDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0003-4198-8679
Mohammad F BayanDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0002-1736-1799
Ali HmedatDepartment of Pharmaceutical Technology and Pharmaceutics, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
Bilal A Al-JaidiDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0003-3308-8697
Deniz M Al-TawalbehDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0001-8671-1134
Duaa AbuarqoubDepartment of Pharmacology and Medical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.ORCID 0000-0001-5277-5703
Anas J RasrasDepartment of Chemistry, Faculty of Science, Al-Balqa Applied University, P.O. Box 206, Al-Salt 19117, Jordan.ORCID 0000-0003-4203-7031
Da'san M M JaradatDepartment of Chemistry, Faculty of Science, Al-Balqa Applied University, P.O. Box 206, Al-Salt 19117, Jordan.ORCID 0000-0002-9853-3272
Abdel Naser DakkahDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.
Wafa HouraniDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.
Rajshekhar KarpoormathDepartment of Pharmaceutical Chemistry, College of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa.ORCID 0000-0002-1247-5754

Funding

Deanship of Scientific Research Philadelphia University 467/34/100 PU
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADME predictionanticancer agentscell cycle analysisHsp90molecular dockingthieno[2,3-c]pyridines

Identifiers

PMID40005967
PMCPMC11858597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.